PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first “Phagogram Day”
PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at…
PHAXIAM Reports Third-Quarter 2024 Financial Information
Cash and cash equivalents of €5.7 million as of September 30, 2024Execution…
Monthly information related to total number of voting rights and shares composing the share capital October 31, 2024
Monthly information related to total number of voting rights and shares composing…